CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,282 | -15.9% | 25,114 | 0.0% | 0.19% | -4.9% |
| Q2 2023 | $270,227 | +105046.7% | 25,114 | 0.0% | 0.20% | +1.0% |
| Q1 2023 | $257 | -3.0% | 25,114 | 0.0% | 0.20% | +7.5% |
| Q4 2022 | $265 | -99.9% | 25,114 | 0.0% | 0.19% | -17.6% |
| Q3 2022 | $322,000 | -44.3% | 25,114 | -44.3% | 0.23% | -46.0% |
| Q2 2022 | $578,000 | +22.5% | 45,114 | 0.0% | 0.42% | +23.5% |
| Q1 2022 | $472,000 | -32.2% | 45,114 | 0.0% | 0.34% | -24.3% |
| Q4 2021 | $696,000 | -31.6% | 45,114 | 0.0% | 0.45% | -35.2% |
| Q3 2021 | $1,018,000 | -12.4% | 45,114 | 0.0% | 0.69% | -0.3% |
| Q2 2021 | $1,162,000 | -53.6% | 45,114 | -25.0% | 0.70% | -53.3% |
| Q1 2021 | $2,505,000 | – | 60,114 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |